ReviewBritish journal of clinical pharmacology2009
Obesity treatment: novel peripheral targets.
Review in British journal of clinical pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 63 citations in OpenAlex.
- Anti-obesity medications impacting the eye: An emerging concern - a narrative review.World journal of methodology · 2026Review
- Cichoriin, a Biocoumarin, Mitigates Oxidative Stress and Associated Adverse Dysfunctions on High-Fat Diet-Induced Obesity in Rats.Life (Basel, Switzerland) · 2022Article
- Antioxidant, Anti-Obesity, Nutritional and Other Beneficial Effects of Different Chili Pepper: A Review.Molecules (Basel, Switzerland) · 2022Review
- Genes in human obesity loci are causal obesity genes in C. elegans.PLoS genetics · 2021Article
- Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review.Neuropsychiatric disease and treatment · 2019Article
- Attenuation of High-Fat Diet-Induced Rat Liver Oxidative Stress and Steatosis by Combined Hydroxytyrosol- (HT-) Eicosapentaenoic Acid Supplementation Mainly Relies on HT.Oxidative medicine and cellular longevity · 2018Article
- Article
- Anti-obesogenic and antidiabetic effects of plants and mushrooms.Nature reviews. Endocrinology · 2017Review
- Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?World journal of gastroenterology · 2014Review
- Obesity vaccines.Human vaccines & immunotherapeutics · 2014Review
- Effects of exercise training on gut hormone levels after a single bout of exercise in middle-aged Japanese women.SpringerPlus · 2013Article
- Obesity pharmacotherapy: current perspectives and future directions.Current cardiology reviews · 2013Review
- Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome.Proceedings of the National Academy of Sciences of the United States of America · 2013Article
- Unraveling oxyntomodulin, GLP1's enigmatic brother.The Journal of endocrinology · 2012Review
- Anti-obesity drugs: past, present and future.Disease models & mechanisms · 2012Review
- GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities.British journal of pharmacology · 2012Review
- Diet-induced obesity blunts the behavioural effects of ghrelin: studies in a mouse-progressive ratio task.Psychopharmacology · 2012Article
- Comparative efficiency and safety of pharmacological approaches to the management of obesity.Diabetes care · 2011Article
- Antipsychotic drugs and obesity.Trends in molecular medicine · 2011Review
- Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity.BMC physiology · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Our knowledge of the complex mechanisms underlying energy homeostasis has expanded enormously in recent years. Food intake and body weight are tightly regulated by the hypothalamus, brainstem and reward circuits, on the basis both of cognitive inputs and of diverse humoral and neuronal signals of nutritional status. Several gut hormones, including cholecystokinin, glucagon-like peptide-1, peptide YY, oxyntomodulin, amylin, pancreatic polypeptide and ghrelin, have been shown to play an important role in regulating short-term food intake. These hormones therefore represent potential targets in the development of novel anti-obesity drugs. This review focuses on the role of gut hormones in short- and long-term regulation of food intake, and on the current state of development of gut hormone-based obesity therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.